Clinical trial Recruiting at 10 sites Interventional Ages 18 and up

Hypertension Treatment in Nigeria: HEARTS-D Integration for Diabetes Care

Official title: Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design - Aim 3

Run by Washington University School of Medicine · NCT07589387 · Data updated 2026-11-12

This program tests a HEARTS-D bundle in 10 primary health centers in Nigeria to help people with diabetes manage blood pressure and glucose using new tools and training.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2800 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations10 sites (Abaji and 9 other locations)
StatusRecruiting
StartedFebruary 14, 2026
Main results expectedApril 30, 2029
Study endsJanuary 31, 2030
Registry record updatedOctober 16, 2026
Trial IDNCT07589387 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with a prior or new diabetes diagnosis and elevated glucose measures who are already on or started on glucose-lowering therapy.

Probably not a fit

Patients without access to the full HEARTS-D bundle or who do not meet glucose criteria may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study expands the HEARTS framework to integrate diabetes care at primary health centers in the Federal Capital Territory. It uses the HEARTS-D package, metformin and other diabetes meds, point-of-care glucose testing, and targeted training with quarterly supervision for community health workers. Adults with diabetes or suspected diabetes who meet specific glucose thresholds are enrolled and registered for the program. The focus is on how integrated management affects diabetes control alongside hypertension across previously involved centers. Geographic sites include Abaji and Abuja-area PHCs, under collaboration among Washington University, NHLBI, and local hospitals.

Why it matters

Potential benefit: If successful, patients may experience better diabetes and hypertension control through a streamlined, team-based care approach.

How similar studies have gone: Similar HEARTS-based programs have improved cardiovascular risk factors in primary care settings, though diabetes integration is being tested in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aim 3 Inclusion Criteria:

Patients will be screened for diabetes with symptoms of hyperglycemia or BMI \>25 kg/m2 and over the age of 18 years old. Upon first or previous diagnosis, diabetes patients will be registered.

* Adults (≥18 years),
* Patients with previous diabetes diagnosis
* Patients with persistently elevated random glucose \>200 mg/dl, fasting glucose \>126 mg/dl, or hemoglobin A1c \>6.5% on two or more occasions (when available)
* Patients taking glucose lowering medications
* Pregnant women are eligible for this program, or
* Cognitively impaired adults are eligible for this program.

Exclusion Criteria:

* \- This program will not include any of the following special populations:

  * Individuals who are not yet adults (minors): i.e. infants, children, or teenagers \<18 years old, or
  * Prisoners or other detained individuals.

Where it's running

  • New Township Abaji
    Abaji, Nigeria
    Recruiting
  • Gbagarape PHC
    Abuja, Nigeria
    Recruiting
  • Gidan Mangoro
    Abuja, Nigeria
    Recruiting
  • Pyakasa PHC
    Abuja, Nigeria
    Recruiting
  • Byazhin
    Bwari, Nigeria
    Recruiting
  • Gtc Gwagwalada
    Gwagwalada, Nigeria
    Recruiting
Show 4 more locations
  • Old Kutunku
    Gwagwalada, Nigeria
    Recruiting
  • Kuje PHC
    Kuje, Nigeria
    Recruiting
  • Dabi Bako
    Kwali, Nigeria
    Recruiting
  • Kawli
    Kwali, Nigeria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.